Inflammation-induced alterations in the skin barrier function: Implications in atopic dermatitis

Chemical Immunology and Allergy

Volumn 96, Issue , 2012, Pages 77-80

  Vestergaard, Christian ^a   Hvid, Malene ^b   Johansen, Claus ^a   Kemp, Kaare ^c   Deleuran, Bent ^b   Deleuran, Mette ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c LEO PHARMA A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 14; FILAGGRIN; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 14; PROFILAGGRIN; INTERLEUKIN 25; INTERLEUKIN 4;

ATOPIC DERMATITIS; CONFORMATIONAL TRANSITION; CYTOKINE PRODUCTION; DRY SKIN; ECZEMA; HUMAN; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; REVIEW; SKIN INFLAMMATION; STRATUM CORNEUM; TH2 CELL; WATER LOSS; ARTICLE; DISEASE EXACERBATION; INFLAMMATION; PATHOGENESIS; PERMEABILITY BARRIER; SKIN BARRIER; SKIN WATER LOSS;

CYTOKINES; DERMATITIS, ATOPIC; HUMANS; INFLAMMATION; INTERMEDIATE FILAMENT PROTEINS; SKIN;

EID: 84859168210     PISSN: 16602242     EISSN: 16622898     Source Type: Book Series    
DOI: 10.1159/000331889     Document Type: Review

References (11)

1. Bieber T: Atopic dermatitis. N Engl J Med 2008;358: 1483-1494.
2. Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, et al: Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol 2009;129:1892-1908.
3. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al: Common loss-offunction variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006;38:441-446.
4. Sandilands A, Sutherland C, Irvine AD, McLean WH: Filaggrin in the frontline: Role in skin barrier function and disease. J Cell Sci 2009;122:1285-1294.
5. Denecker G, Ovaere P, Vandenabeele P, Declercq W: Caspase-14 reveals its secrets. J Cell Biol 2008;180: 451-458.
6. Denecker G, Hoste E, Gilbert B, Hochepied T, Ovaere P, Lippens S, et al: Caspase-14 protects against epidermal UVB photodamage and water loss. Nat Cell Biol 2007;9:666-674.
7. Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, Debenedetto A, et al: Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007;120:150-155.
8. Hvid M, Johansen C, Deleuran B, Kemp K, Deleuran M, Vestergaard C: Regulation of caspase 14 expression in keratinocytes by inflammatory cytokines-a possible link between reduced skin barrier function and inflammation? Exp Dermatol 2011;20:633-636.
9. Hvid M, Vestergaard C, Kemp K, Christensen GB, Deleuran B, Deleuran M: IL-25 in atopic dermatitis: A possible link between inflammation and skin barrier dysfunction? J Invest Dermatol 2011;131:150-157.
10. Jakasa I, Koster ES, Calkoen F, McLean WH, Campbell LE, Bos JD, et al: Skin barrier function in healthy subjects and patients with atopic dermatitis in relation to filaggrin loss-of-function mutations. J Invest Dermatol 2011;131:540-542.
11. McGrath JA, Uitto J: The filaggrin story: Novel insights into skin-barrier function and disease. Trends Mol Med 2008;14:20-27.